These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20537948)

  • 41. Cases and evidence for panel testing in cancer genetics: Is site-specific testing dead?
    Thomas MH; Higgs LK; Modesitt SC; Schroen AT; Ring KL; Dillon PM
    J Genet Couns; 2019 Jun; 28(3):700-707. PubMed ID: 30706980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Spectrum of Genetic Testing.
    Smith LP
    Semin Oncol Nurs; 2019 Feb; 35(1):11-21. PubMed ID: 30660358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes.
    Howard HC; Knoppers BM; Cornel MC; Wright Clayton E; Sénécal K; Borry P; ; ;
    Eur J Hum Genet; 2015 Dec; 23(12):1593-600. PubMed ID: 25626707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic counselling: evolution or involution?
    Frontali M; Jacopini AG
    Community Genet; 2000; 3(4):175-8. PubMed ID: 11878343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Are we ready for direct-to-consumer genetic testing?
    Burton A
    Lancet Neurol; 2015 Feb; 14(2):138-9. PubMed ID: 25772890
    [No Abstract]   [Full Text] [Related]  

  • 46. Genetic testing to identify high-risk populations for chemoprevention studies.
    Velasquez JL; Lipkin SM
    Cancer Biomark; 2007; 3(3):163-8. PubMed ID: 17611307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent advances of genetic ancestry testing in biomedical research and direct to consumer testing.
    Via M; Ziv E; Burchard EG
    Clin Genet; 2009 Sep; 76(3):225-35. PubMed ID: 19793051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Advantages and disadvantages of direct-to-consumer genetic tests].
    Christiansen CW; Gerdes AA
    Ugeskr Laeger; 2017 Mar; 179(11):. PubMed ID: 28330535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growing complexity of (expanded) carrier screening: Direct-to-consumer, physician-mediated, and clinic-based offers.
    Chokoshvili D; Vears DF; Borry P
    Best Pract Res Clin Obstet Gynaecol; 2017 Oct; 44():57-67. PubMed ID: 28302443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Biochips--tools of 21st century medicine].
    Bürger J
    Versicherungsmedizin; 2006 Mar; 58(1):9-13. PubMed ID: 16553220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changing interpretations, stable genes: responsibilities of patients, professionals, and policy makers in the clinical interpretation of complex genetic information.
    Shirts BH; Parker LS
    Genet Med; 2008 Nov; 10(11):778-83. PubMed ID: 18941419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing the social impact of direct-to-consumer genetic testing: understanding sociotechnical architectures.
    Parthasarathy S
    Genet Med; 2010 Sep; 12(9):544-7. PubMed ID: 20601894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An epidemiological perspective on the future of direct-to-consumer personal genome testing.
    Janssens AC; van Duijn CM
    Investig Genet; 2010 Oct; 1(1):10. PubMed ID: 21092344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Genetic testing in daily clinical practice according to the guidelines : How do we proceed?].
    Wolpert C
    Herzschrittmacherther Elektrophysiol; 2024 Mar; 35(1):25-30. PubMed ID: 38180540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dermatologic applications of direct-to-consumer genomic analysis.
    Fogel AL; Azizi N; Tang J; Sarin KY
    J Am Acad Dermatol; 2014 Nov; 71(5):993-5. PubMed ID: 25437956
    [No Abstract]   [Full Text] [Related]  

  • 56. Are health professionals ready for direct-to-consumer genetic and genomic testing?
    Skirton H; Jackson L; Goldsmith L; O'Connor A
    Per Med; 2013 Sep; 10(7):673-682. PubMed ID: 29768754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Greater goods?: Direct-to-consumer testing companies are making a broader case for societal benefits, but not everyone is sold.
    Nelson B
    Cancer Cytopathol; 2016 Mar; 124(3):159-60. PubMed ID: 26972119
    [No Abstract]   [Full Text] [Related]  

  • 58. Fertility care in the era of commercial direct-to-consumer home DNA kits: issues to ponder.
    Rotshenker-Olshinka K; Dahan MH
    J Assist Reprod Genet; 2020 Mar; 37(3):689-692. PubMed ID: 32103399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic testing and counselling.
    Liang R
    Hong Kong Med J; 2018 Aug; 24(4):328-329. PubMed ID: 30100580
    [No Abstract]   [Full Text] [Related]  

  • 60. Genetic counseling for patients with positive genomic screening results: Considerations for when the genetic test comes first.
    Schwartz MLB; Buchanan AH; Hallquist MLG; Haggerty CM; Sturm AC
    J Genet Couns; 2021 Jun; 30(3):634-644. PubMed ID: 33786929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.